Conference Coverage

Sexual dysfunction, depression common in endometriosis patients


 

AT WCE 2017

– Endometriosis is associated with an increased risk of a range of sexual dysfunctions, and depression and anxiety are also common, according to a study conducted in Brazilian women.

Depression and anxiety were so common that the study itself had to be altered. Almost a third of participants were excluded from the study due to depressive symptoms. So many, in fact, that the researchers decided to include patients with mild to moderate depression and anxiety, and ultimately exclude only those with severe symptoms.

Dr. Flavia Fairbanks of the Univesity of San Paolo, Brazil

Dr. Flavia Fairbanks

The researchers initially interviewed 1,001 women sequentially at three centers in Brazil. After initial screening with the Beck Anxiety Inventory and the Beck Depression Inventory, they excluded 30% of the women from further analysis because of severe symptoms. “It was a lot of women,” said Flavia Fairbanks, MD, PhD, coordinator of the gynecological division of ProSex program on human sexuality at the University of São Paulo, who presented the research at the World Congress on Endometriosis.

The final sample included 254 women with endometriosis and 329 control subjects between 18 and 45 years old. They all had an active sex life in the previous 6 months, and were heterosexual.

Forty-three percent of women in the endometriosis group had sexual dysfunction, compared with 18% in the control group (P less than .001), as measured by the Female Sexual Quotient. They also had higher rates of individual types of sexual dysfunction, including sexual desire dysfunction (25% vs. 16%; P = .007); sexual arousal dysfunction (16% vs. 4%; P less than .001); pain during intercourse/sex dysfunction (46% vs. 16%; P less than .001); and orgasm and/or sexual satisfaction dysfunction (30% vs. 13%; P less than .001).

The researchers also examined the relationship between sexual dysfunction and psychological factors, and found statistically significant positive associations with anxiety and depression.

The underlying psychological issues are of particular concern to Dr. Fairbanks. “It’s the main step to begin anything with them. We have to know if they have anxiety and depression or not,” she said.

Her team now asks patients with endometriosis about their sex life in order to establish a baseline that can be referred to. “After 1 year, 2 years, 5 years, we reapply the questionnaire to show them that their sexual life was not so good in the beginning.”

The study was eye-opening to Lori Brotto, PhD, professor of gynecology at the University of British Columbia, Vancouver, who was a discussant at the session. “The call to action is for doctors to really pay attention to sexual dysfunction, even though that might not be the primary issue that brings the patient to them,” Dr. Brotto said.

The high rates of depression and anxiety also suggest a need for a more rounded approach to endometriosis treatment. “A physician may think, ‘we’ll treat the endometriosis, and all other parts of her should improve as well.’ This study suggests that primarily physical interventions may not be sufficient for addressing something like sexual health, which is really mind and body together,” said Dr. Brotto.

The study was not funded. Dr. Fairbanks and Dr. Brotto reported having no relevant financial disclosures.

Recommended Reading

Physicians favor ACOG mammography recommendations
MDedge Internal Medicine
Neurokinin receptor antagonist nearly halves hot flashes
MDedge Internal Medicine
Liposomal bupivacaine cut need for opioids after gyn surgery
MDedge Internal Medicine
Genital HPV prevalence tops 42% in adults
MDedge Internal Medicine
Postmenopausal hot flashes cut by 93% with novel nonhormonal treatment
MDedge Internal Medicine
VIDEO: Bile acid malabsorption as a cause of chronic diarrhea
MDedge Internal Medicine
Beware hormonal IUD expulsion in obese women
MDedge Internal Medicine
Endometrial cancer rates increased following WHI
MDedge Internal Medicine
Deep infiltrating endometriosis lesions harbor cancer-driver mutations
MDedge Internal Medicine
USPSTF discourages postmenopausal hormone therapy for prevention
MDedge Internal Medicine